Clinical Trial Update: The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 trial evaluating inhaled nitric oxide for reducing dyspnea and improving exercise tolerance in COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University of Alberta | Conditions: Dyspnea | Phase 1, Phase 2 | Status: COMPLETED